Precision is the first CRO designed specifically to apply a biomarker-driven, precision medicine approach to oncology therapeutic development. Our end-to-end integration of assays, translational informatics, and full-scale trial execution coupled with expertise in novel and adaptive trial methodologies optimizes the entire oncology development pathway.
Broad expertise in oncology studies: We have conducted over 350 oncology clinical trials across disease types and drug classes. Our team applies this experience to support you in planning trial designs, regulatory strategy, biomarker assays, data collection, and data analysis, creating the foundation for developmental success.
Customized biomarker assays that inform trial design: We support your assay needs with a broad array of technologies and techniques customized for oncology—including IHC, pathology, multiplexed imaging, liquid biopsy, and multiple immune monitoring solutions appropriate for any trial phase.
An established global network of oncology sites for rapid study startup: The Oncology Site NetworkTM, our specialized network of worldwide academic and community trial sites, enables us to carefully align site capabilities with protocol requirements while ensuring deep expertise in all phases and indications of oncology trials. Our global logistics network spans 55+ countries, further enabling rapid sample collection and processing.
To learn more about Precision’s specific clinical trial solutions for oncology, please visit the Precision for Medicine, Oncology and Rare Disease site.